Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer

BACKGROUND: Studies conducted in Swedish populations have shown that men with lowest prostate-specific antigen (PSA) levels at ages 44–50 years and 60 years have very low risk of future distant metastasis or death from prostate cancer. This study investigates benefits and harms of screening strategi...

Full description

Saved in:
Bibliographic Details
Published in:J Natl Cancer Inst
Main Authors: Heijnsdijk, Eveline A M, Gulati, Roman, Tsodikov, Alex, Lange, Jane M, Mariotto, Angela B, Vickers, Andrew J, Carlsson, Sigrid V, Etzioni, Ruth
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566340/
https://ncbi.nlm.nih.gov/pubmed/32067047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items